Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessWire NewsShasun Pharmaceuticals falls on Vertex drug warning

    Shasun Pharmaceuticals falls on Vertex drug warning

    SHASUN-PHARMACEUTICALS-FALLS:Shasun Pharmaceuticals falls on Vertex drug warning

    December 20, 2012 / 16:19 IST

    Reuters Market Eye - Shasun Pharmaceuticals falls 6 percent after its Vertex Pharmaceuticals warned on Wednesday its hepatitis C drug Incivek, which is used in conjunction with two other products, can cause serious, potentially fatal skin reactions.

    Shasun has a long-term agreement with Vertex for supply of active pharmaceutical ingredient for the Hepatitis C drug.

    "There would be incremental impact on Shasun as about 25 percent of FY13 profits were expected to come in from Incivek supply," said Surya Patra, an analyst tracking the sector at Systematix Shares & Stocks.

    (Reporting by Abhishek Vishnoi)

    first published: Dec 20, 2012 02:30 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347